
|Articles|January 4, 2016
University of Wisconsin-Madison School of Pharmacy CE Programs
Guest host Blair Green Thielemier, PharmD, interviews Dr. Alan L Hanson, Division Chair and Professor at Melvin H. Weinswig University of Wisconsin-Madison School of Pharmacy.
Advertisement
Guest host Blair Green Thielemier, PharmD, interviews Dr. Alan L Hanson, Division Chair and Professor at Melvin H. Weinswig University of Wisconsin-Madison School of Pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
5

















































































































































































































